Literature DB >> 7917847

Production and characterisation of monoclonal antibodies against pyelonephritis-associated P-pili of Escherichia coli.

H Miyata1, S Kataoka, N Moriguchi, T Yamamoto, I Michibata, T Kobayashi, S Maki.   

Abstract

Pyelonephritis-associated P-pili (PAP) of Escherichia coli O6,H(-),K1(-),F12,haemolysin(-) were purified by salt precipitation and affinity chromatography using Synsorb P1. Purified PAP showed a single band with a molecular weight of 18 kDa by electrophoretic analysis. A monoclonal antibody (mAb) was produced by fusion of the PAI myeloma cell line with splenic lymphocytes from BALB/c mice immunised with the purified PAP. The mAb was of IgM class with kappa light chains and reacted with a 18-kDa moeity of the salt precipitate; the epitope was present near the apical part of the pilus filaments. The mAb reacted with PAP in both immunofluorescence and haemagglutination tests when 108 strains isolated from urine samples were tested; the two tests were in agreement for 202 of 204 strains isolated from faecal samples.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917847     DOI: 10.1007/bf00866329

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Genetics of digalactoside-binding adhesin from a uropathogenic Escherichia coli strain.

Authors:  S Normark; D Lark; R Hull; M Norgren; M Båga; P O'Hanley; G Schoolnik; S Falkow
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

2.  Monoclonal antibodies with fimbrial F1C, F12, F13, and F14 specificities obtained with fimbriae from E. coli 04:K12:H-.

Authors:  C Abe; S Schmitz; I Moser; G Boulnois; N J High; I Orskov; F Orskov; B Jann; K Jann
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

3.  Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters.

Authors:  B Lund; F P Lindberg; M Båga; S Normark
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

4.  Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli.

Authors:  G Källenius; S Svenson; R Möllby; B Cedergren; H Hultberg; J Winberg
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

5.  Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection.

Authors:  A Pere; B Nowicki; H Saxén; A Siitonen; T K Korhonen
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

6.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

7.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

Review 8.  Tip proteins of pili associated with pyelonephritis: new candidates for vaccine development.

Authors:  B Lund; F Lindberg; B I Marklund; S Normark
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

9.  Binding of Escherichia coli S fimbriae to human kidney epithelium.

Authors:  T K Korhonen; J Parkkinen; J Hacker; J Finne; A Pere; M Rhen; H Holthöfer
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Production of monoclonal antibodies against calmodulin by in vitro immunization of spleen cells.

Authors:  R L Pardue; R C Brady; G W Perry; J R Dedman
Journal:  J Cell Biol       Date:  1983-04       Impact factor: 10.539

View more
  1 in total

1.  Antigenic phenotypes of Escherichia coli in urine from patients with urinary tract infections.

Authors:  H Miyata; S Kataoka; N Moriguchi; T Yamamoto; I Michibata; K Matui; S Maki
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.